Covered recipient · General Payments record
NATHALIE CHRISTINE DE GUZMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2024
$408.52
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.52 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $119.28 | 1 |
| Kiniksa Pharmaceuticals International, plc | $118.08 | 1 |
| GENZYME CORPORATION | $67.33 | 2 |
| ABBVIE INC. | $48.31 | 2 |
| Amgen Inc. | $29.34 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.18 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $408.52 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.63 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106999761 | CMS |
| ABBVIE INC. | $24.68 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106999763 | CMS |
| Amgen Inc. | $29.34 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117538886 | CMS |
| GENZYME CORPORATION | $42.61 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139982764 | CMS |
| GENZYME CORPORATION | $24.72 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139982770 | CMS |
| Janssen Biotech, Inc. | $119.28 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078299553 | CMS |
| Kiniksa Pharmaceuticals International, plc | $118.08 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154866743 | CMS |
| Novartis Pharmaceuticals Corporation | $26.18 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086956629 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.